Atsushi Ochiai

15PUBLICATIONS
69CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 08, 2025
EML4-ALK Rearrangement Creates a Distinctive Myeloid Cell-Dominant Immunosuppressive Microenvironment in Lung Cancer.

Kosuke Arai, Yukari Nishito, Hideaki Mizuno

|Mar 25, 2024
Molecular subtypes of lung adenocarcinoma present distinct immune tumor microenvironments.

Hironori Fukuda, Kosuke Arai, Hideaki Mizuno

|Sep 29, 2023
Metabolic Hallmarks for Purine Nucleotide Biosynthesis in Small Cell Lung Carcinoma.

Sho Tabata, Shigeki Umemura, Miyu Narita

|Aug 22, 2023
Fibroblast inhibition by tocilizumab enabled gemcitabine/nab-paclitaxel rechallenge for pancreatic cancer.

Shuichi Mitsunaga, Masafumi Ikeda, Hiroshi Imaoka

Pageof 3